Abstract:The gut and tumor microbiome have been shown to affect tumorigenesis, tumor immune infiltration, and response to traditional cancer therapeutics such as radiation therapy. Further, specific microbe-cancer relationships have been established. One such microbe is Candida albicans, which has been identified within several gastrointestinal cancers and is associated with an increased risk of metastases and decreased overall survival. By completing RNA-sequencing on murine rectal tumors colonized with C. albicans, we can better understand whether intratumoral changes in gene expression exist based on colonization of specific microbes. This study utilizes gut-to-tumor translocation and whole transcriptome analysis for a discovery-based approach to identify the effects of C. albicans on the host tumor. We established a rectal tumor model with C57BL/6 mice using MC38 rectal cancer cells subcutaneously injected on the right flank, local radiation to the tumor (standard-of-care for rectal cancer), and gavage with either C. albicans (Ca) or PBS. Fungal presence within tumors was validated by staining with calcofluor white and subsequently, tumors were sent for bulk RNA-sequencing to determine differences in gene expression using DeSeq2 and a gene set enrichment analysis (GSEA). In unsupervised analysis of gene expression differences between PBS-gavaged and Ca-gavaged with bulk RNA sequencing, tumors gavaged with C. albicans possessed unique gene expression and pathway analysis when compared to PBS-gavaged mice. Global differential gene expression showed 1,947 genes upregulated in Ca gavage and 593 genes upregulated in the PBS gavage (p < 0.05). C. albicans colonized tumors showed decreased expression in gene pathways relating to immune activation (interferon alpha response, IL-6 and STAT3 signaling), p53 expression, DNA repair, oxidative phosphorylation, NOTCH signaling, and apoptosis. We subsequently used a network-based approach to identify the most important genes driving the differences in the tumors, calculating the degree, closeness, and betweenness centralities. Several microbes have been regarded as potential contributors to decreased treatment response and survival in rectal cancer. In the case of tumors colonized with C. albicans, bulk RNA-sequencing indicates down regulation of gene pathways related to cell proliferation, immune activation, and DNA maintenance. Down regulation of gene pathways related to cell cycle control and arrest suggests that intratumoral colonization of C. albicans may causally affect tumorigenesis. Decreases in immune signaling in tumors suggest a potentially causal role of C. albicans immune suppression. These results highlight initial steps to understand how intratumoral C. albicans may be affecting rectal cancer progression and treatment response and serve as a technique to allow better insight to individual microbial impact on tumors. Citation Format: Alexander Loncar, Dennis Grencewicz, Rebecca Hoyd, Aaditya Pallerla, Nyelia Williams, Martin Benej, Yogita Mehra, Shiva Jahanbakhshi, Matthew Anderson, Nicholas Denko, Daniel Spakowicz. The effect of intra-tumoral Candida albicans on host gene expression [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6842.

Candida albicans induce hypoxia response via activating EGFR to promote colorectal cancer progression

Hypoxic Colorectal Cancer Cells Promote Metastasis of Normoxic Cancer Cells Depending on IL-8/p65 Signaling Pathway

Fungal‐induced Glycolysis in Macrophages Promotes Colon Cancer by Enhancing Innate Lymphoid Cell Secretion of IL‐22

Candida tropicalis induces NLRP3 inflammasome activation via glycogen metabolism-dependent glycolysis and JAK-STAT1 signaling pathway in myeloid-derived suppressor cells to promote colorectal carcinogenesis

Fungal dysbiosis of the gut microbiota is associated with colorectal cancer in Chinese patients

<i>Candida</i><i> tropicalis</i> induces NLRP3 inflammasome activation via glycogen metabolism-dependent glycolysis and JAK-STAT1 signaling pathway in myeloid-derived suppressor cells to promote colorectal carcinogenesis

Abstract 1282: Gavage with Candida albicans leads to fungal colonization of colorectal tumors and decreased response to radiotherapy

Gut fungi enhances immunosuppressive function of myeloid-derived suppressor cells by activating PKM2-dependent glycolysis to promote colorectal tumorigenesis

Candida Albicans Promotes Oral Cancer Via IL-17A/IL-17RA-Macrophage Axis.

Candida albicans overgrowth disrupts the gut microbiota in mice bearing oral cancer

Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2α signaling

Candida albicans induces upregulation of programmed death ligand 1 in oral squamous cell carcinoma

Abstract 6842: The effect of intra-tumoral Candida albicans on host gene expression

Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming

Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy

IL-1β mediates Candida tropicalis-induced immunosuppressive function of MDSCs to foster colorectal cancer

Candida Albicans-Myeloid Cells-T Lymphocytes Axis in the Tumor Microenvironment of Oral Tumor-Bearing Mice

C. tropicalis promotes chemotherapy resistance in colon cancer through increasing lactate production to regulate the mismatch repair system

Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis

Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner

Receptor-kinase EGFR-MAPK adaptor proteins mediate the epithelial response to Candida albicans via the cytolytic peptide toxin, candidalysin